The blind spot undermining pharma product launches – and how to eliminate it
Something critical is missing: a clear view of what’s actually happening on the ground
Read More
Thought Leadership
Closing the last mile: translating national market access into real-world patient access in the UK
UK market access needs the right conditions nationally, along with subnational investment and delivery locally
Read More
Why HCP AI use is now a brand strategy opportunity for pharma
For pharma brands, AI visibility is no longer just a digital question, it is fast becoming a brand strategy imperative
Read More
Ramping up human-centricity in trial design
Making the experience better for people living with a health condition begins by including them
Read More
GenAI is a new audience for medcomms: ensure your message is heard
By Rosie Morland and Rayman Vaid
Read More
Where patient insight meets strategy: measuring what truly matters
By Stephen O’Farrell
Read More
Why the field is critical tonext-generation marketing
AI is fundamentally changing the way marketing operates omnichannel journeys, enabling true next-best communication
Read More
AI-powered launches on a limited budget: a playbook for emerging biopharma
Every AI decision must drive better outcomes and add greater value for clients
Read More
Beyond the injection: why the real work of weight loss starts where the drug leaves off
Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward
Read More
Achieving comms excellence through personalised engagement
By Daniel Gibbs
Read More